Technical Analysis for RHNMF - Rhinomed Ltd

Grade Last Price % Change Price Change
grade D 0.11 -24.71% -0.0361
RHNMF closed down 24.71 percent on Tuesday, February 12, 2019, on 6 percent of normal volume. The bears made the stock sink to a new 52-week low.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A N/A
See historical RHNMF trend table...

Date Alert Name Type % Chg
Feb 12 New 52 Week Closing Low Bearish 0.00%
Feb 12 Hot IPO Pullback Bullish Swing Setup 0.00%
Feb 12 Narrow Range Bar Range Contraction 0.00%
Feb 12 New 52 Week Low Weakness 0.00%
Feb 12 Gapped Down Weakness 0.00%
Feb 5 Gapped Down Weakness -24.71%
Jan 11 Gapped Up Strength -31.25%
Jan 10 New 52 Week Closing Low Bearish -21.43%
Jan 10 Narrow Range Bar Range Contraction -21.43%
Jan 10 New 52 Week Low Weakness -21.43%

Older signals for RHNMF ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Rhinomed Limited, a medical technology company, researches, develops, and commercializes consumer and medical devices. The company identifies, acquires, and commercializes late stage therapeutic delivery technologies. It markets Turbine, a nasal dilator designed to assist to breathe easier during aerobic exercise; and Mute, a nasal dilator designed to enhance sleep quality by breathing more and snoring less. The company also develops Breathing Space Health that comprises of a range of wellness programs designed to help people get to sleep. In addition, it develops Sleep Apnea, a clinical trial solution to mild and moderate sleep apnea; creates drug delivery platform for delivering medication into the nose in an inhaled form or via a trans-dermal or trans-mucosal method; and researches and develops current programs focuses on olfactory pathway and wearable technology. The company sells its products through wholesalers, retail stores, and clinics, as well as online in the United States, Canada, the United Kingdom, Taiwan, Australia, and New Zealand. It serves clinicians and health care organizations. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is based in Cremorne, Australia.
Medicine Biology Retail Stores Medical Technology Drug Delivery Sleep Disorders Physiology Sleep Apnea Apnea Wearable Technology Snoring
Is RHNMF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.19
52 Week Low 0.11
Average Volume 35,400
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 0.0
Average True Range 0.0
ADX 0.0
+DI 0.0
-DI 0.0
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line 0.0
MACD Signal Line 0.0
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.1100
Resistance 3 (R3) 0.1100 0.1100 0.1100
Resistance 2 (R2) 0.1100 0.1100 0.1100 0.1100
Resistance 1 (R1) 0.1100 0.1100 0.1100 0.1100 0.1100
Pivot Point 0.1100 0.1100 0.1100 0.1100 0.1100
Support 1 (S1) 0.1100 0.1100 0.1100 0.1100 0.1100
Support 2 (S2) 0.1100 0.1100 0.1100 0.1100
Support 3 (S3) 0.1100 0.1100 0.1100
Support 4 (S4) 0.1100